ELIZABETH TINIOS: Open Payments
NPI 1952855835 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$407 in 18 payments from 11 companies in 2025. Trend: 2023 $17 · 2024 $722 · 2025 $407
Food & beverage: $407
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $174 |
| Ardelyx, Inc. | 2 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Seqirus USA Inc | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Exact Sciences Corporation | 1 | $19 |
| PFIZER INC. | 1 | $16 |
| Novo Nordisk Inc | 1 | $15 |
Products named: LINZESS, UBRELVY, VIBERZI, IBSRELA, JARDIANCE, REXULTI, CAPLYTA, Fluad.
Industry payments across MA — which companies pay providers there.
